Neoadjuvant PD-1 blockade combined with chemotherapy for patients with resectable locally advanced esophageal squamous cell carcinoma (ESCC): A real world data analysis

被引：4
作者：
Lv, H. [1 ]
Tian, Y. [2 ]
Huang, C. [1 ]
Sun, B. [1 ]
Gai, C. [1 ]
Li, Z. [1 ]
Tian, Z. [1 ]
机构：
[1] Fourth Hosp Hebei Med Univ, Dept Thorac Surg, Shijiazhuang, Hebei, Peoples R China
[2] Hangzhou Hosp Tradit Chinese Med, Dept Thorac & Cardiac Surg, Hangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.128
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
110P
引用
收藏
页码：S1423 / S1423
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant sintilimab combined with chemotherapy in patients with resectable esophageal squamous cell carcinoma (ESCC): Preliminary results from a phase II study.
    Guo, Jincheng
    Qiao, Chengrui
    Lu, Jiabin
    Yang, Shiqing
    Zhang, Boyi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16008 - E16008
  • [42] Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma.
    Zhang, Xu
    Yang, Guozhen
    Su, Xiaodong
    Luo, Guangyu
    Cai, Peiqiang
    Zheng, Yating
    Bei, Ting
    Gao, Chan
    Huang, Mengli
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Neoadjuvant PD-1 blockade combined with chemotherapy followed by concurrent immunoradiotherapy for locally advanced anal canal squamous carcinoma patients: Antitumor efficacy, safety and biomarker.
    Xiao, Weiwei
    Yuan, Yan
    Wang, SuiHai
    Cai, Peiqiang
    Chen, BaoQing
    Zhang, Rong
    Zeng, ZhiFan
    Gao, Yuanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] Individualized neoadjuvant PD-1 inhibitors combined with chemotherapy for resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC): A single-center, retrospective trial
    Chen, X.
    Li, Z.
    Li, P.
    Xu, H.
    Yang, Z.
    Li, L.
    Zhou, J.
    Ding, Y.
    ANNALS OF ONCOLOGY, 2024, 35
  • [45] NEOADJUVANT CAMRELIZUMAB IN COMBINATION WITH ALBUMIN PACLITAXEL AND CISPLATIN FOR PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
    Lv, Huilai
    Tian, Yang
    Li, Zhenhua
    Huang, Chao
    Xu, Yanzhao
    Tian, Ziqiang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A587 - A587
  • [46] Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma
    Leng, Xue-Feng
    Daiko, Hiroyuki
    Han, Yong-Tao
    Mao, You-Sheng
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1482 (01) : 213 - 224
  • [47] Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II trial.
    Chen, Yueyun
    Ding, Zhen-Yu
    Yuan, Yong
    Yang, Yu-Shang
    Lin, Zhen
    Tian, Jiangfang
    Liu, Ting
    Yue, Zheng
    Shi, Hua-Shan
    Hu, Yang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 352 - 352
  • [48] Neoadjuvant chemoradiotherapy versus chemotherapy and surgery for patients with locally advanced esophageal squamous cell carcinoma
    Hao, Daxuan
    Li, Xue
    Yang, Yuanyuan
    Zhang, Yougai
    Wu, Xiaoyuan
    Chen, Yongshun
    Wang, Jianhua
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (02) : 346 - 353
  • [49] Neoadjuvant chemoradiotherapy versus chemotherapy and surgery for patients with locally advanced esophageal squamous cell carcinoma
    Hao, Daxuan
    Li, Xue
    Yang, Yuanyuan
    Zhang, Yougai
    Wu, Xiaoyuan
    Chen, Yongshun
    He, Chunyu
    Wang, Wen
    Liu, Jinsong
    Wang, Jianhua
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [50] The efficacy and safety of neoadjuvant sintilimab combined with chemotherapy in elderly patients with locally advanced esophageal squamous cell carcinoma.
    Lv, Huilai
    Huang, Chao
    Li, Jiachen
    Zhang, Fan
    Gai, Chunyue
    Liu, Zhao
    Xu, Shi
    Wang, Mingbo
    Li, Zhenhua
    Tian, Ziqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 378 - 378
12345